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Label-free separation of human embryonic stem cells and their cardiac derivatives using 
Raman spectroscopy
JW Chan1, DK Lieu1,2, TR Huser1, RA Li1,2,3 
1Applied Physics and Biophysics Division, Physical Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, CA, 
United States
2Stem Cell and Regenerative Medicine Program, Department of Medicine and HBHA, The University of Hong Kong, Hong Kong
3Division of Cardiology, Department of Medicine, The University of Hong Kong, Hong Kong
Self-renewable, pluripotent human embryonic stem cells (hESCs) can be differentiated into cardiomyocytes 
(CMs), providing an unlimited source of cells for transplantation therapies. However, unlike certain cell 
lineages such as haematopoietic cells, CMs lack specific surface markers for convenient identification, 
physical separation, and enrichment. Identification by immunostaining of cardiac-specific proteins such as 
troponin requires permeabilisation, which renders the cells unviable and non-recoverable. Ectopic expression 
of a reporter protein under the transcriptional control of a heart-specific promoter for identifying hESC-
derived CMs (hESC-CMs) is useful for research but complicates potential clinical applications. The practical 
detection and removal of undifferentiated hESCs in a graft, which may lead to tumours, is also critical. Here, 
we demonstrate a non-destructive, label-free optical method based on Raman scattering to interrogate the 
intrinsic biochemical signatures of individual hESCs and their cardiac derivatives, allowing cells to be identified 
and classified. By combination of the Raman spectroscopic data with multivariate statistical analysis, our results 
indicate that hESCs, human foetal left ventricular CMs, and hESC-CMs can be identified by their intrinsic 
biochemical characteristics with an accuracy of 96%, 98%, and 66%, respectively. The present study lays the 
groundwork for developing a systematic and automated method for the non-invasive and label-free sorting of 
(1) high-quality hESCs for expansion, and (2) ex-vivo CMs (derived from embryonic or adult stem cells) for cell-
based heart therapies.
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Introduction: Adiponectin is an anti-inflammatory adipokine and is thought to play a role in chronic obstructive 
pulmonary disease (COPD) pathogenesis. This study was to investigate plasma levels of adiponectin, interleukin 
(IL)-8, and C-reactive protein (CRP) in ever-smokers with or without COPD.
Methods: Plasma levels of adiponectin, IL-8, and CRP were measured using commercially available kits 
respectively in COPD patients (n=71), healthy ever-smokers (n=62), and non-smokers (n=51). Pulmonary 
function test was also carried out for all subjects recruited in this study.
Results: There were significant increases in plasma adiponectin and CRP in COPD patients (median [IQR], 4.39 
μg/mL [2.68-6.98 μg/mL] and 8.75 mg/L [4.26-40.63 mg/L] respectively) compared to healthy ever-smokers (1.90 
μg/mL [0.86-2.86 μg/mL] and 3.71 mg/L [1.97-10.37 mg/L] respectively; P<0.001) and non-smokers (1.76 μg/mL 
[1.34-2.52 μg/mL] and 3.12 mg/L [2.11-5.71 mg/L] respectively; P<0.001). Patients with COPD, however, had a lower 
plasma IL-8 than healthy ever-smokers. Plasma adiponectin and CRP increased with COPD severity while IL-8 
was reduced. Among ever-smokers with or without COPD, plasma adiponectin and CRP levels were inversely 
correlated with FEV1 (% predicted) after adjustment for age, body mass index, smoking status, and pack-years 
smoked. 
Conclusion: Plasma adiponectin levels are associated with disease severity in COPD patients, suggesting a 
possible role in the pathogenesis of COPD.
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